243 related articles for article (PubMed ID: 31505061)
1. Plasmablastic lymphoma achieving sustained remission with antiretroviral therapy alone.
Atallah-Yunes SA; Murphy D; Abdelmalak R; Mantle L; Ali SS
Eur J Haematol; 2019 Dec; 103(6):620-622. PubMed ID: 31505061
[TBL] [Abstract][Full Text] [Related]
2. Impact of highly active antiretroviral therapy in the development and remission of oral plasmablastic lymphoma.
Wagner VP; Ortiz L; da Silva HP; Meurer L; da Cunha Filho JJ; Martins MA; Martins MD
Indian J Dent Res; 2016; 27(5):559-562. PubMed ID: 27966518
[TBL] [Abstract][Full Text] [Related]
3. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium.
Noy A; Lensing SY; Moore PC; Gupta N; Aboulafia D; Ambinder R; Baiocchi R; Dezube BJ; Henry D; Kaplan L; Levine AM; Mitsuyasu R; Ratner L; Reid E; Remick S; Sparano J; Tzachanis D; Wachsman W; Chadburn A
Leuk Lymphoma; 2016 Jul; 57(7):1731-4. PubMed ID: 26674561
[No Abstract] [Full Text] [Related]
4. HIV-associated oral plasmablastic lymphoma and role of adherence to highly active antiretroviral therapy.
Francischini E; Martins FM; Braz-Silva PH; Magalhães MH; Ortega KL
Int J STD AIDS; 2010 Jan; 21(1):68-70. PubMed ID: 19884361
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
Koizumi Y; Uehira T; Ota Y; Ogawa Y; Yajima K; Tanuma J; Yotsumoto M; Hagiwara S; Ikegaya S; Watanabe D; Minamiguchi H; Hodohara K; Murotani K; Mikamo H; Wada H; Ajisawa A; Shirasaka T; Nagai H; Kodama Y; Hishima T; Mochizuki M; Katano H; Okada S
Int J Hematol; 2016 Dec; 104(6):669-681. PubMed ID: 27604616
[TBL] [Abstract][Full Text] [Related]
6. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases.
Lester R; Li C; Phillips P; Shenkier TN; Gascoyne RD; Galbraith PF; Vickars LM; Leitch HA
Leuk Lymphoma; 2004 Sep; 45(9):1881-5. PubMed ID: 15223650
[TBL] [Abstract][Full Text] [Related]
7. Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy.
Nasta SD; Carrum GM; Shahab I; Hanania NA; Udden MM
Leuk Lymphoma; 2002 Feb; 43(2):423-6. PubMed ID: 11999580
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.
Castillo JJ; Furman M; Beltrán BE; Bibas M; Bower M; Chen W; Díez-Martín JL; Liu JJ; Miranda RN; Montoto S; Nanaji NM; Navarro JT; Seegmiller AC; Vose JM
Cancer; 2012 Nov; 118(21):5270-7. PubMed ID: 22510767
[TBL] [Abstract][Full Text] [Related]
9. Durable complete remission with combination chemotherapy and bortezomib in HIV-associated plasmablastic lymphoma.
Arora N; Gupta A; Sadeghi N
BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28993364
[TBL] [Abstract][Full Text] [Related]
10. Oral plasmablastic lymphoma: A case report.
Zizzo M; Zanelli M; Martiniani R; Sanguedolce F; De Marco L; Martino G; Parente P; Annessi V; Manzini L; Ascani S
Medicine (Baltimore); 2020 Sep; 99(39):e22335. PubMed ID: 32991445
[TBL] [Abstract][Full Text] [Related]
11. Plasmablastic lymphoma in a previously undiagnosed AIDS patient: a case report.
Vieira FO; El Gandour O; Buadi FK; Williams GB; Shires CB; Zafar N
Head Neck Pathol; 2008 Jun; 2(2):92-6. PubMed ID: 20614329
[TBL] [Abstract][Full Text] [Related]
12. Plasmablastic lymphoma in pediatric patients: clinicopathologic study of three cases.
Pather S; MacKinnon D; Padayachee RS
Ann Diagn Pathol; 2013 Feb; 17(1):80-4. PubMed ID: 23036261
[TBL] [Abstract][Full Text] [Related]
13. HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients.
Mai B; Wang W; Lin M; Hu S; Wang XI; Chen L; Wahed A; Nguyen A; Ma HY; Medeiros LJ; Hu Z
AIDS; 2020 Oct; 34(12):1735-1743. PubMed ID: 32889849
[TBL] [Abstract][Full Text] [Related]
14. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.
Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T
J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211
[TBL] [Abstract][Full Text] [Related]
15. Plasmablastic lymphoma in Johannesburg, South Africa, in the era of widescale antiretroviral therapy use.
Vaughan J; Perner Y; Mayne E; Wiggill T
HIV Med; 2021 Mar; 22(3):225-230. PubMed ID: 33022825
[TBL] [Abstract][Full Text] [Related]
16. Dramatic treatment response of cutaneous plasmablastic lymphoma in an HIV patient: a case report.
Sakib SM; Sadler M
Clin Imaging; 2016; 40(6):1067-1069. PubMed ID: 27408991
[TBL] [Abstract][Full Text] [Related]
17. [Long-term complete remission of HIV-negative primary testicular plasmablastic lymphoma treated with bortezomib in combination with EPOCH].
Fujishima T; Kawabata Y; Michishita Y; Kitabayashi A; Takahashi N
Rinsho Ketsueki; 2022; 63(10):1386-1391. PubMed ID: 36351644
[TBL] [Abstract][Full Text] [Related]
18. Stage IV advanced diffuse large B-cell lymphoma in human immunodeficiency virus infection with achieving cure by using highly active antiretroviral therapy alone: a case report.
Lim DH; Rhee JY; Park KW
Int J STD AIDS; 2017 Aug; 28(9):932-936. PubMed ID: 28094666
[TBL] [Abstract][Full Text] [Related]
19. HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy.
Castelli R; Schiavon R; Preti C; Ferraris L
Cardiovasc Hematol Disord Drug Targets; 2020; 20(3):175-180. PubMed ID: 32294049
[TBL] [Abstract][Full Text] [Related]
20. Oral Plasmablastic Lymphoma: A Rare Manifestation of HIV-Related Neoplasm-A Brief Clinical Study.
Ramyasri M; Singh V; Mohan Rangan N; Roy ID; Tomar K; Desai AP; Yadav R; Krishnan M
J Craniofac Surg; 2024 Jun; 35(4):e321-e325. PubMed ID: 38363301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]